In the last trading session, 1.53 million shares of the Virpax Pharmaceuticals Inc (NASDAQ:VRPX) were traded, and its beta was 0.90. Most recently the company’s share price was $0.33, and it changed around -$0.06 or -14.91% from the last close, which brings the market valuation of the company to $2.29M. VRPX currently trades at a discount to its 52-week high of $5.48, offering almost -1560.61% off that amount. The share price’s 52-week low was $0.36, which indicates that the current value has fallen by an impressive -9.09% since then. We note from Virpax Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 17.87 million shares, with the 3-month average coming to 3.16 million.
Virpax Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended VRPX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Virpax Pharmaceuticals Inc (NASDAQ:VRPX) trade information
Instantly VRPX has showed a red trend with a performance of -14.91% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4780 on recent trading dayincreased the stock’s daily price by 30.96%. The company’s shares are currently down -89.61% year-to-date, but still down -27.85% over the last five days. On the other hand, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) is -53.31% down in the 30-day period. We can see from the shorts that 0.35 million shares have been sold at a short interest cover period of 1.04 day(s).
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 89.0% from its current value. Analyst projections state that VRPX is forecast to be at a low of $3 and a high of $3.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -20.69%.
VRPX Dividends
Virpax Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in January.
Virpax Pharmaceuticals Inc (NASDAQ:VRPX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.72% of Virpax Pharmaceuticals Inc shares, and 1.90% of them are in the hands of institutional investors. The stock currently has a share float of 1.97%. Virpax Pharmaceuticals Inc stock is held by 10.0 institutions, with PARALLEL ADVISORS, LLC being the largest institutional investor. By 2024-06-30, it held 0.0001% of the shares, which is about 1.0 shares worth $1.0.
